About the investment
- GHO invests in the European Healthcare sector.
- Focuses on healthcare sectors with high growth potential.
- Experienced team with strong relationships in the sector.
Through our investment with Global Health Opportunities, key investments are:
Caprion Biosciences
- World-leading clinical research.
- Caters to biotechnology and pharmaceutical industries.
- Develops diagnostic tools targeting cancer, metabolic and infectious diseases.
Envision Pharma Group
- Innovative global technology and scientific communication company.
- Services pharmaceutical, biotechnology and medical device sectors.
- Uses smart technology to help biopharma companies manage data communication.
Roslin CT
- Started in 2006 to extend the use of the technology it developed to clone the first mammal - Dolly the sheep.
- Applies this technology to development of human medicines.
Velocity Clinical Research
- Delivers high-quality clinical trial data and patient care.
- Partners with research companies to support drug, medical device and other diagnostic product research.
Members in our Core and Socially Conscious diversified investment options will have exposure to this investment.
Members in our Indexed or single asset class options will not have exposure.
Find out more about Global Health Opportunities, opens in a new window